Found: 10
Select item for more details and to access through your institution.
The first reported case of drug-induced hemolytic anemia caused by dimethyl fumarate in a patient with multiple sclerosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comparative Assessment of Simoa and Lumipulse for Measuring Serum Neurofilament Light Chain in Multiple Sclerosis Patients.
- Published in:
- Acta Neurologica Scandinavica, 2024, v. 2024, p. 1, doi. 10.1155/2024/1950913
- By:
- Publication type:
- Article
Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Transient autoimmune hyperthyroidism following the withdrawal of Natalizumab in patients with multiple sclerosis.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Functional and structural changes in the visual pathway in multiple sclerosis.
- Published in:
- Brain & Behavior, 2019, v. 9, n. 12, p. N.PAG, doi. 10.1002/brb3.1467
- By:
- Publication type:
- Article
Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.727586
- By:
- Publication type:
- Article
Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 7, p. 3676, doi. 10.1007/s00415-022-10989-0
- By:
- Publication type:
- Article
Observational Study of Switching from Natalizumab to Immunomodulatory Drugs.
- Published in:
- European Neurology, 2017, v. 77, n. 3/4, p. 130, doi. 10.1159/000453333
- By:
- Publication type:
- Article
Fatigue Improvement after Switching Multiple Sclerosis Treatment from Interferon-β to Glatiramer Acetate in Clinical Practice.
- Published in:
- European Neurology, 2016, v. 76, n. 1/2, p. 40, doi. 10.1159/000447630
- By:
- Publication type:
- Article